US 5,672,586 AGranted

Herpes ribonucleotide reductase inhibitors

AssigneeBio-Mega/Boehringer Ingelheim Research Inc.

InventorsJean Andre Gauthier, Neil Moss

Life of this patent

Estimating the term…

Abstract

Disclosed herein are compounds of the formula ##STR1## wherein R.sup.1 is hydrogen or (1-4C) alkyl, R.sup.2 is (1-4C) alkyl or a therapeutically acceptable salt thereof. The compounds are useful for treating herpes infections.

Claims22

Dependent claims

A compound of formula 1 ##STR9## wherein R.sup.1 is hydrogen or (1-4C)alkyl and R.sup.2 is (1-4C)alkyl;

or a therapeutically acceptable salt thereof.

Dependencies are inferred from the claim text.

Facts

Application: 08/666,732Filed 18 Jun 1996
Priority: CA 215254123 Jun 1995
Granted: 30 Sep 1997
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

C07C 237/22
Having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton: having nitrogen atoms of amino groups…
A61P 31/12
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antivirals
A61P 31/22
For DNA viruses: for herpes viruses
C07K 14/005
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from viruses

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results